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Abstract
Tick-borne encephalitis (TBE) virus causes severe encephalitis with serious sequelae in humans. The disease is characterized
by fever and debilitating encephalitis that can progress to chronic illness or fatal infection. In this study, changes in
permeability of the blood-brain barrier (BBB) in two susceptible animal models (BALB/c, and C57Bl/6 mice) infected with TBE
virus were investigated at various days after infection by measuring fluorescence in brain homogenates after intraperitoneal
injection of sodium fluorescein, a compound that is normally excluded from the central nervous system. We demonstrate
here that TBE virus infection, in addition to causing fatal encephalitis in mice, induces considerable breakdown of the BBB.
The permeability of the BBB increased at later stages of TBE infection when high virus load was present in the brain (i.e., BBB
breakdown was not necessary for TBE virus entry into the brain), and at the onset of the first severe clinical symptoms of the
disease, which included neurological signs associated with sharp declines in body weight and temperature. The increased
BBB permeability was in association with dramatic upregulation of proinflammatory cytokine/chemokine mRNA expression
in the brain. Breakdown of the BBB was also observed in mice deficient in CD8
+ T-cells, indicating that these cells are not
necessary for the increase in BBB permeability that occurs during TBE. These novel findings are highly relevant to the
development of future therapies designed to control this important human infectious disease.
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Introduction
Diseases that affect the central nervous system (CNS) also
frequently alter the function of the blood-brain barrier (BBB) [1–
5]. The BBB is formed by epithelial-like, high-resistance, tight
junctions within the endothelium in capillaries perfusing the
vertebrate brain, and represents a physical barrier between the
bloodstream and the brain parenchyma. Integrity of the BBB is
important for regulating the flow of nutrients from the blood to the
brain and restricting access of toxins, pathogens, and other
substances that are harmful to the CNS. Moreover, the BBB also
restricts the access of inflammatory cell to the CNS, which protects
irreplaceable cells (such as neurons) from damage [5].
Studies in models of CNS autoimmunity and virus-induced
neuroinflammation have provided evidence linking the develop-
ment of a CNS inflammatory response with enhanced BBB
permeability. For example, an increase in BBB permeability has
been associated with CNS inflammation in multiple sclerosis [6],
experimental allergic encephalomyelitis [7], Borna disease [8],
lymphocytic choriomeningitis [1], mouse adenovirus type 1
encephalomyelitis [5], rabies virus infection [9], West Nile virus
(WNV) encephalitis [10], Japanese encephalitis virus (JEV)
infection [11], Semliki Forest encephalitis, Banzi virus encephalitis
[4], and in neuroAIDS [12]. It may be expected that enhanced
BBB permeability is required to allow circulating immune cells
contact with CNS tissue-derived chemokines, as well as to allow
immune effectors to infiltrate CNS tissues. However, the exact
mechanism of BBB breakdown and its role in the disease
progression of viral encephalitis remain largely unknown [4].
Tick-borne encephalitis (TBE) is a human viral infectious
disease involving the CNS, and is caused by the TBE virus (TBEV;
family Flaviviridae, genus Flavivirus). The disease most often
manifests as meningitis, encephalitis, or meningoencephalitis.
More than 13,000 human clinical cases of TBE are reported
across Europe and Asia annually. The number of TBE cases in all
endemic regions of Europe has increased dramatically in the last
30 years; risk areas have spread and new foci have been discovered
[13]. Therefore, TBE has become a growing public health
problem.
Although TBEV is a neurotropic virus, the mechanisms
underlying how TBEV gains access to the CNS are not completely
understood [14,15]. There are several hypothetical routes for the
entry of TBEV into the CNS, including direct crossing of the BBB
[14]. The mode by which TBEV crosses the BBB is unknown;
however, several different hypotheses exist. These include (i)
cytokine-mediated BBB breakdown, (ii) ‘‘Trojan horse’’ theory,
and (iii) virus entry into the vascular endothelial cells of brain
capillaries, transcytosis, and the release of virus into the brain
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cytokines such as tumor necrosis factor alpha (TNF-a)a n di n t e r l e u k i n
6 (IL-6) increase BBB permeability, which in turn can lead to the
passage of virus into the CNS [10]. In human TBE patients, increased
serum levels of TNF-a were observed during the first week of
hospitalization [16]. Moreover, experiments on rats and mice showed
that IL-6 causes disruption of the BBB [17]. The so-called ‘‘Trojan
horse’’ mechanism isbased on the migration of TBEV-infectedcells of
the immune system (e.g., d e n d r i t i cc e l l s ,n e u t r o p h i l s ,m o n o c y t e s ,
macrophages, T-cells) through the BBB into the CNS, and
initialization of TBEV infection in the CNS tissue [14]. Infection
and replication of TBEV in endothelial cells or the choroid plexus and
budding of the virus on the parenchymal side represent another
possible explanation. However, in fatal TBE cases, TBEV antigens
were not detectable in endothelial cells from brain sections. In patients
with a severe form of TBE, neurospecific proteins such as a-1 brain
globulin or neuron-specific enolase were elevated in serum, indicating
BBB breakdown [18,19].However,despite this finding, dysfunction of
the BBB has not been extensively studied in TBE so far.
In this study, we focused on BBB permeability during TBEV
infection in two strains of mice. We reveal that infection of mice
with TBEV increases BBB permeability and that BBB breakdown
is largely independent of the presence of CD8
+ T-cells. Moreover,
we clearly demonstrate that the degree of BBB permeability
corresponds with proinflammatory cytokine/chemokine expres-
sion in the brain, and consequently with disease progression.
Results
Groups of BALB/c and C57Bl/6 mice were subcutaneously
inoculated with 100 pfu of the TBEV strain Neudoerfl/IRE. These
two mouse strains with predominantly different Th immune
responses (Th1 and Th2, for C57Bl/6 and BALB/c, respectively)
were selected because of their different susceptibility to some viral
neuroinfections [20], including Far Eastern TBEV [21]. Moreover,
a previous report demonstrated a difference in BBB permeability
between these strains (i.e., elevated permeability in C57Bl/6, but
not inBALB/c miceafterWNV inoculation) [22]. Survival rateand
average survival times of TBEV-infected mice were compared.
Following the same TBEV challenge, observed mortality was 70%
in BALB/c mice and 80% in C57Bl/6 mice (Figure 1A). Although
BALB/c mice exhibited a slightly longer mean survival time
(19.066.0 days) in comparison with C57Bl/6 mice (15.066.7 days),
the difference was not statistically significant (p.0.05).
Mouse body weight and temperature were determined prior to
infection, and then daily throughout the course of the experiment,
to determine relation of body weight and temperature (as
indicators of the disease progression) with changes in BBB
permeability. Body weight increased slightly during the first three
days of infection. At days 4 and 5 post-inoculation (p.i.), there was
a decrease in body weight in both mouse strains. This decrease was
not statistically significant, but it was reproducible. After day 5 p.i.,
body weight again increased slightly. However, both strains of
mice showed a sharp decrease in body weight beginning on day 10
p.i. in both mouse strains. A statistically significant decrease in
body weight (p,0.05) was observed from days 12 and 13 p.i. in
C57Bl/6 and BALB/c mice, respectively. At the termination of
the experiment (on day 16 p.i.), most animals weighed approx-
imately 85% of their original body weight (Figure 1B).
Similarly, the body temperature of infected mice decreased
significantly (p,0.05) starting from day 12 and 13 p.i. in C57Bl/6
and BALB/c mice, respectively (Figure 1C). Mice with abnormally
low body temperature (less than 32uC) were euthanized. None of
the mice developed fever during the experiment.
Decreases in body weight and temperature corresponded with
an appearance of clinical symptoms of the disease. All TBEV-
inoculated mice remained asymptomatic for several days. Starting
on day 10–13 p.i., most mice developed bristle coat, hunched
back, and lethargic movement. Later, the disease symptoms
progressed to lethargy with paralysis.
Serum samples and brains were harvested for titration at
various time points during the experiment. The virus titers in the
individual samples were determined by plaque assay on PS cells.
Peak viremia was detected in both mouse strains on day 4 p.i. and
reached approximately 3–3.5 log10 pfu/ml. From day 7 p.i. to the
termination of the experiment, no virus was detected in any serum
sample. Virus in the brain was first detected on day 7 p.i. in both
mouse strains. Subsequently, the virus titer in brains of both mouse
strains increased rapidly and reached a maximum of approx-
imately 6–6.5 log10 pfu/g (Figure 2).
TBEV-infected mice were assayed for BBB integrity at different
time points using sodium fluorescein, a compound that is normally
excluded from the CNS, and compared with mock-infected
individuals. As measured by the leakage of sodium fluorescein from
the circulation into the CNS tissues, BBB permeability began rising
at day 10 p.i. in both mouse strains (i.e., when high virus titer was
present in the brain, at the appearance of severe clinical signs of
infection).Evidenceofsodiumfluorescein accumulationinthebrain
parenchyma was also observed when intact brains from infected
mice were examined under ultraviolet (UV) light (Figure 3). The
values of brain fluorescence in BALB/c and C57Bl/6 mice reached
similar levels; however, the basal fluorescence was slightly higher in
mock-infected BALB/c mouse brains than in brains from C57Bl/6
mice (2–4%) (Figure 4A). In C57Bl/6 mice, the brain fluorescence
reached medium levelsof6–8%of serumfluorescenceat laterstages
of the infection, which is more than 3- to 4-fold higher than the 2%
noted in mock-infected mice (Figure 4B).
The levels of mRNAs specific for the chemokines Regulated
upon Activation, Normal T-cell Expressed, and Secreted
(RANTES); C-C motif ligand 5 (CCL5); monocyte chemotactic
protein-1 (MCP-1, also known as CCL2); macrophage inflamma-
tory protein-1a (MIP-1a, also known as CCL3); MIP-1b (CCL4);
and interferon-c-inducible protein-10 (IP-10) were determined in
the brain tissue of TBEV-infected BALB/c and C57Bl/6 mice at
various times p.i. and compared with levels in the brains of
uninfected mice (Figure 5). At day 9 p.i., before the BBB becomes
significantly impaired, RANTES, MCP-1, IP-10, and to a lesser
extent MIP-1b were slightly, but significantly (p,0.05) elevated in
both infected mouse strains. On day 12 (BALB/c) or 11 p.i.
(C57Bl/6) (i.e., during significant BBB disruption) expression of all
chemokines was dramatically elevated. The highest increases were
observed in IP-10, MCP-1, and RANTES mRNA levels. At the
termination of the experiment, the increases of IP-10, MIP-1a,
and MIP-1b mRNAs were lower than on days 11 or 12 p.i. in both
mouse strains (Figure 5).
Similarly, the mRNA expression of proinflammatory cytokines
TNF-a, IL-6, and IFN-c became significantly (p,0.05) upregu-
lated on day 9 p.i. in both mouse strains (i.e., one day before BBB
permeability increased). Subsequently, the expression dramati-
cally increased and remained at high levels until the termination
of the experiment. TNF-a and IL-6 expression are of particular
interest, because of their known contribution to increasing BBB
permeability. Inter-cellular adhesion molecule-1 (ICAM-1)
mRNA levels became increased on day 11 and 14 (C57Bl/6),
or 12 and 15 (BALB/c) p.i. Interestingly, infected BALB/c mice
exhibited a stronger IFN-c response than C57Bl/6 mice, while
C57Bl/6 mice had greater upregulation of TNF-a mRNA
expression (Figure 5).
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cells (CD19), T helper cells (CD4), cytotoxic T cells (CD8b), and
macrophage/monocyte/granulocyte/NK cells (CD11b) in brain
tissue after TBEV infection were determined. CD8b, CD4,
CD11b, and CD19 mRNA in brain tissue became significantly
higher (p,0.05) than those of normal uninfected mice by day 9
p.i., and continued to accumulate until the termination of the
experiment. The increase was the highest in case of CD8b mRNA,
Figure 1. The effects of TBEV infection on BALB/c and C57Bl/6 mice. (A) Survival of BALB/c (n=10) and C57Bl/6 (n=10) mice subcutaneously
inoculated with TBEV (100 pfu). (B) Body weight change ratio (as compared to the day 0) and (C) daily temperature fluctuation in TBEV-infected BALB/
c (n=10) and C57Bl/6 (n=10) mice. For each time point the measured values are the average of the surviving mice. Error bars represent standard
deviations. Statistically significant (p,0.05) decreases in body weight/temperature at different time points versus the beginning of the experiment
are marked by an asterisk (C57Bl/6) or hash (BALB/c).
doi:10.1371/journal.pone.0020472.g001
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CD19 mRNA. The kinetics were analogous in infected BALB/c
and C57Bl/6 mice (Figure 5).
To determine whether TBEV-induced breakdown of the BBB is
mediated by the migration of CD8
+ T-cells into the brain
parenchyma, an animal model lacking CD8
+ T-cells (CD8a
2/2
mice) was employed. CD8a
2/2 mice exhibited slower develop-
ment of the disease in comparison with the parent C57Bl/6 mice.
The neurological signs appeared in CD8a
2/2 mice approximately
on days 16–17 p.i. Viral loads in the brains of CD8a
2/2 mice
during the neurological stage of infection were slightly higher (6.7–
7.7 log10 pfu/g) when compared to the brains of BALB/c and
C57Bl/6 mice. All investigated infected mice showed breakdown
of the BBB, as detected by an increase in brain sodium flourescein
levels compared to mock-infected mice. Brain fluorescence
reached medium levels of approximately 8% of serum fluorescence
at later stages of the infection in CD8a
2/2 mice, which is more
than 5-fold higher than the 1-1.5% noted in mock-infected mice
(Figure 6A). This difference was statistically significant (p,0.05).
Clear evidence of sodium fluorescein accumulation in the brains of
moribund CD8a
2/2 mice was also observed when intact brains
from infected and control mice were examined macroscopically
under UV light (Figure 6B). Therefore, BBB breakdown occurs in
both immunocompetent and CD8a
2/2 mice, despite the lack of
CD8
+ T-cell mediated inflammation in CD8a
2/2 mice.
Relative mRNA quantitation by real-time RT-PCR showed
that the CD8a deficiency had no effect on cytokine or chemokine
mRNA levels in the brain tissue of infected mice. At the terminal
phase of infection (phase of neurological signs of the disease), the
levels of all chemokines/cytokines tested were analogous in TBEV-
infected CD8a
2/2 mice and in C57Bl/6 mice on day 14 p.i.
(Figure 5). Similarly, the levels of CD4, CD11b, and CD19 mRNA
in the brains of infected CD8a
2/2 mice reached levels analogous
to those in the brains of infected C57Bl/6 mice. Interestingly,
Figure 2. TBEV burden in serum and brain. (A) BALB/c and (B) C57Bl/6 mice were subcutaneously inoculated with TBEV (100 pfu). Brain and
serum specimens were titrated individually by plaque assay on porcine kidney stable cell monolayers. For each time point the titers are the average
of three mice. Error bars represent standard deviations. Detection limit for serum =1.4 log10 pfu/ml; brain =1.7 log10 pfu/g.
doi:10.1371/journal.pone.0020472.g002
Figure 3. BBB permeability changes in the brains of TBEV-
infected C57Bl/6 mice. Brains were removed from sodium fluores-
cein-treated mice, either uninfected (day 0) or TBEV-infected (days 10
and 11 after inoculation). The brains were photographed under UV
illumination.
doi:10.1371/journal.pone.0020472.g003
Figure 4. Measurement of BBB permeability using sodium
fluorescein in (A) BALB/c and (B) C57Bl/6 mice. All mice were
inoculated subcutaneously with TBEV (100 pfu). BBB permeability is
expressed as brain:serum ratio (%). Thirty minutes after intraperitoneal
injection of sodium fluorescein, the sera and brains were processed as
described in the Material and Methods section and the fluorescence
was measured. Asterisks indicate statistically significant increases in
brain:serum fluorescence in infected versus uninfected mice (p,0.05).
doi:10.1371/journal.pone.0020472.g004
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2/2 mice, we
were able to detect an increase in CD8b mRNA production at
later stages of infection versus the level in uninfected CD8a
2/2
mice. However, this increase was only very slight in comparison
with the remarkable increase observed in infected C57Bl/6 mice.
Discussion
The BBB is more than just a barrier that separates the CNS
from the blood. It is also a crucial regulatory interface through
which nutrients, xenobiotics, cytokines, immune cells, and
pathogens pass into and out of the CNS [12]. Brain homeostasis
is critically dependent on the integrity of the BBB. Alteration of the
BBB is a hallmark feature of many CNS infections and likely has
important effects on disease progression [4]. Encephalitis associ-
ated with breakdown of the BBB can be caused by a number of
encephalitic RNA and DNA viruses [23]. Within the family
Flaviviridae, BBB breakdown was observed in WNV [10], JEV [11],
and dengue [24] infections. We demonstrate here that TBEV
infection, in addition to causing fatal encephalitis in susceptible
mouse strains, also causes breakdown of the BBB. Permeability of
the BBB began rising at the time of the appearance of severe
clinical signs of infection, including neurological symptoms
associated with sharp declines in body weight and temperature
Figure 5. Immune/inflammatory cell accumulation and differential upregulation of cytokine/chemokine gene expression in the
brain after TBEV infection. (A–C) BALB/c, (D–F) C57Bl/6, and (G–I) CD8a
2/2 mice were infected subcutaneously with TBEV (100 pfu). CD8a
2/2
mice were examined at the terminal stage (i.e. phase of neurological signs) of TBEV infection. Data are expressed as the mean + standard deviation of
the fold increase of expression after normalization to the housekeeping gene (mouse beta actin).
doi:10.1371/journal.pone.0020472.g005
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already present in the brain. No increase in BBB permeability was
observed during the viremic phase of the infection. Therefore,
TBEV is able to enter the brain through the intact BBB. Unlike
WNV encephalitis [22], a similar pattern in BBB breakdown was
observed in BALB/c and C57Bl/6 mice. In human patients with
the severe form of TBE, BBB breakdown has been suggested based
on the increased level of neurospecific proteins, such as a-1 brain
globulin or neuron-specific enolase, in serum [18,19]. However,
our study is the first to demonstrate BBB breakdown during TBEV
infection experimentally.
In the case of WNV encephalitis in mice, increased BBB
permeability induced by TNF-a allows WNV to cross into the
CNS [10]. BBB breakdown occurs at day three after infection,
when viremia and WNV burden are high in the periphery [10,25].
BBB breakdown in the context of WNV is dependent on the Toll-
like receptor (TLR)-3, since TLR-3 deficient mice exhibit
increased survival when compared with wild-type mice after
infection. Moreover, CNS inflammatory cytokines, leukocytes,
virus titers, and pathological changes were decreased in TLR-3–
deficient mice [10]. However, these findings seemed to be specific
to WNV only, since the deficiency in TLR-3 had no effect on the
pathogenesis of four other viral infections (lymphocytic chorio-
meningitis virus, vesicular stomatitis virus, murine cytomegalovi-
rus, and reovirus) [26]. Another study demonstrated that the
increased BBB permeability in WNV-infected rodents is not a
primary determinant for lethality [22]. Similarly to our study, an
increase in BBB permeability in correlation with disease
progression was observed in JEV-infected mice [11].
The increase of BBB permeability in TBEV-infected mice
corresponded with excessive mRNA expression of several
chemokines and cytokines in the brain parenchyma. Dramatic
increases in the expression of cytokines/chemokines TNF-a, IL-6,
IFN-c, ICAM-1, RANTES, MCP-1, MIP-1a, MIP-1b, and IP-10
positively correlated with an increase in BBB permeability. C57Bl/
6 mice exhibited a stronger TNF-a response than BALB/c mice,
which is in agreement with the dominant, proinflammatory, Th1-
type immune response of C57Bl/6 mice. On the other hand,
BALB/c mice had higher IFN-c expression, corresponding with a
higher amount of CD8
+ T-cells observed in the brain tissue of
these mice. Expression of ICAM-1 (BALB/c and C57Bl/6), MIP-
1a (BALB/c and C57Bl/6), and MIP-1b (C57Bl/6) became
increased later (i.e., after the initiation of BBB breakdown).
Similarly to our study, the extent of BBB permeability was in direct
association with increased levels of cytokines, clinical sickness, and
virus titer in the brains of JEV-infected mice [27]. Robust release
of some of the investigated cytokines/chemokines in the brains of
TBEV-infected mice has also been recently demonstrated by other
authors [28,29]. It is known that the overproduction of
proinflammatory cytokines, including TNF-a and IL-6, enhances
neuronal injury [30] and increases BBB permeability [31,32].
MCP-1 is also known as an important stimulus capable of causing
BBB breakdown [33,34]. In human TBE patients, the highest
levels of serum TNF-a and IL-6 are observed during the first week
of hospitalization, and treatment reducing these cytokines leads to
quicker improvement and faster recovery [16]. Similarly, increase
of MCP-1 [35] and RANTES [36] in the cerebrospinal fluid of
TBE patients was observed.
Under normal conditions, there are minimal numbers of
lymphocytes detected within the CNS, a resultof reduced penetration
of lymphocytes across the BBB. However, during inflammatory
conditions, there is a significant accumulation of lymphocytes in the
brain parenchyma. It has been demonstrated in several brain
diseases, such as multiple sclerosis, stroke, neuroAIDS, and
Alzheimer’sdisease,that BBB breakdown is associated with leukocyte
migration into the brain [37,38]. Leukocyte recruitment can trigger
signal transduction cascades leading to junctional disorganization and
BBB breakdown [37]. Immune-mediated CNS vascular permeability
is a likely contributor to pathology in infectious CNS disease, and
leukocyte migration into the brain tissue often has devastating
consequences [39,40].
In this study, we have demonstrated that there is significant
increase of cells expressing CD8b antigen in the brain parenchyma
of both BALB/c and C57Bl/6 mice, starting on day 9 p.i. The
amount of CD8b
+ cells increased until the termination of the
experiment. The increase of CD4
+ T-cells was much lower, and
CD11b- and CD19-expressing cells increased slightly but still
significantly. These data indicate that CD8
+ T-cells are the most
prominent lymphocyte population crossing the BBB during TBE.
Dual roles for these cells during TBE (protective and immuno-
pathological) in mice have been demonstrated previously [41].
Moreover, data from histopathological investigation of brains from
human fatal TBE cases support the hypothesis on the immuno-
pathological role of cytotoxic T-cells in TBE [42,43]. However,
the role of CD8
+ T-cells in BBB breakdown during flavivirus
encephalitis remained largely unknown. It has been demonstrated
that antigen-specific CD8
+ T-cells initiate astrocyte activation,
alteration of BBB tight junction proteins, and increased CNS
vascular permeability. Perforin-deficient mice are resistant to tight
junction alterations and CNS vascular permeability, indicating the
Figure 6. Measurement of BBB permeability using sodium
fluorescein in CD8a
2/2 mice. Mice were inoculated subcutaneously
with TBEV (100 pfu). BBB permeability is expressed as brain:serum ratio
(%). (A) Thirty minutes after intraperitoneal injection with sodium
fluorescein, the sera and brains were processed as described in the
Material and Methods section and the fluorescence was measured. Each
line segment represents the mean of four samples (points). The increase
in brain:serum fluorescence in infected versus uninfected mice was
statistically significant (p,0.05). (B) Sodium fluorescein accumulation in
the brains of CD8a
2/2 before infection and at the terminal phase (i.e.
phase with neurological signs) of TBE. The brains were photographed
under UV illumination.
doi:10.1371/journal.pone.0020472.g006
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+ T-cell-
mediated BBB breakdown [44]. In murine lymphocytic chorio-
meningitis, BBB breakdown is mediated by virus-specific CD8
+ T-
cells. These cells are mandatory for the increase in BBB
permeability as well as for mortality [1]. On the contrary,
breakdown of the BBB despite the absence of CD8
+ T-cells has
been observed in mouse adenovirus type-1 encephalomyelitis [5].
To directly test the role of CD8
+ T-cells in the increase of BBB
permeability during TBE, an experimental mouse model lacking a
functional CD8a
+ T-cell population was employed. Interestingly,
significant BBB breakdown was observed at terminal phases of
TBE in these CD8a
2/2 mice. Therefore, TBEV-induced
breakdown of the BBB is largely independent of the presence of
CD8
+ T-cells, although we cannot rule out possible contributions
of these cells to the process. The mRNA expression of cytokines/
chemokines in the brains of these TBEV-infected CD8a
2/2 mice
exhibited similarly increased levels as in TBEV-infected C57Bl/6
mice, indicating that even this phenomenon was not significantly
affected by the absence of CD8a
+ T-cells. The same is true for the
increase of mRNAs specific for CD4, CD11b, and CD19 antigens.
The role of the other inflammatory cells in the development of
BBB breakdown remains unknown.
The mode of TBEV entry into the brain is largely unknown. A
variety of flaviviruses have been speculated to enter the CNS via the
olfactory pathway [45,46] or across cerebral capillary endothelial
cells [11,47]. In this study, we showed that TBEV entry into the
brain is not dependent on the breakdown of the BBB, but that BBB
breakdown is a consequence of virus infection of the brain.
Experiments with an in vitro BBB model may provide more
information on the direct interaction of TBEV with brain
microvascular endothelial (BMVE) cells, the main component of
the BBB. A study on WNV demonstrated that human BMVE cells
are susceptible to WNV infection and that cell-free WNV can cross
the BBB withoutcompromisingthe integrity oftheBBB.These data
suggest that infection of BMVE cells can facilitate the entry of cell-
free virus into the CNS without disturbing the BBB [48].
In summary, we demonstrate here that TBE is associated with
dramatic BBB breakdown occurring at later stages of infection
when high virus titer is present in the brain, and the severe clinical
symptoms appear. BBB breakdown is not necessary for TBEV
entry to the brain and is not dependent on the migration of CD8
+
T-cells into the brain. It more likely represents a bystander effect of
virus-induced cytokine/chemokine overproduction in the brain.
With respect do difficulties of drug delivery thought intact BBB
under normal conditions, these novel findings are highly relevant
to the development of therapies designed to control this serious
human infection.
Materials and Methods
Mice
BALB/c and C57Bl/6 mice were obtained from Charles River
Laboratories (Sulzfeld, Germany). CD8a-knockout mice of the
C57Bl/6 background (CD8a
2/2; strain B6.129S2-Cd8atm1Mac)
were obtained from The Jackson Laboratory (BarHarbor, ME,
USA). Sterilized pellet diet and water were supplied ad libitum. In
all experiments, female mice aged 7–9 weeks were used. The mice
were housed in plastic cages with wood-chip bedding, situated in a
specific pathogen-free room with a constant temperature of 22uC
and a relative humidity of 65%.
Virus infection
The mice were infected subcutaneously with 100 pfu of TBEV,
strain Neudoerfl/IRE. This strain was passaged three times in
suckling mice and once in Ixodes ricinus cells (cell line IRE/
CTVM19 [49]). In comparison to mice infected with highly
passaged TBEV strains, Neudoerfl/IRE-infected mice exhibit
longer mean survival time and increased survival. The parental
strain, Neudoerfl, was originally isolated from the tick I. ricinus in
Austria in 1971. The virus has been extensively characterized,
including its complete genome sequence (GenBank accession
number U17495), and the determination of the three-dimensional
structure of its envelope protein E [50].
The body weight and temperature of infected mice were
measured daily. Rectal temperature was determined using the
Rodent Thermometer BIO-TK9882 (Bioseb).
BBB permeability assay
Sodium fluorescein (Sigma-Aldrich), a low molecular mass
molecule (376 Da), was used to detect fluid shifts between the
circulation and CNS, which occur when BBB permeability
becomes enhanced [9]. Mice were injected with 10 mg sodium
fluorescein in 0.1 ml sterile saline i.p. Thirty minutes later, animals
were anesthesized with ketamine-HCl (100–200 mg/kg), cardiac
blood was collected, and mice were perfused with PBS to remove
blood from the intravascular compartment. Brains were removed,
individually weighed, and stored at 270uC until processing.
Homogenization of brain tissues was performed in 1 ml sterile
PBS using TissueLyser II (Qiagen). The homogenate was clarified
by centrifugation at 140006 g for 10 min, at 4uC. Protein was
precipitated with trichloroacetic acid (TCA) to remove potential
background fluorescence. The supernatant was diluted 1:10 in
15% TCA. Serum samples were initially diluted 1:10 in PBS and
subsequently 1:10 in 15% TCA. All samples were incubated at
4uC overnight. Samples were then centrifuged at 140006 g for
10 min, 4uC, and the supernatant was diluted 1:1 in borate buffer
(0.05 M, pH 10). The amount of fluorescein in each sample was
determined using standards ranging from 125 to 3000 mg in 7.5%
TCA and 0.025 borate buffer on an Infinite M200 fluorometer
(Tecan) using an excitation wavelength of 480 nm, and fluores-
cence was read at 538 nm.
The uptake ratio was expressed as the ratio of the amount of
sodium fluorescein measured in the brain to the amount measured
in serum.
To visualize sodium fluorescein accumulation in different
regions of the CNS, the brain was exposed to UV light using
the Visi-Blue UV Transilluminator (UVP Laboratory Products),
and photographed with an Olympus X-710 digital camera.
Plaque assay
The virus titers in brain homogenates and sera of infected mice
were estimated by plaque assay on porcine kidney stable cell
monolayers under a carboxymethyl-cellulose overlay, as described
previously [51]. Infectivity was expressed in plaque-forming units
(pfu) per ml of serum or g brain tissue.
Real-time quantitative RT-PCR
Brain tissue pellets prepared as described above were used to
quantify the expression levels of specific mRNAs in the CNS.
RNA was isolated from the pellet using the RNeasy Mini Kit
(Qiagen), according to the recommendations of the manufacturer.
cDNA was synthesized using a High Capacity RNA-to-cDNA Kit
(Applied Biosystems), according to the manufacturer’s protocol.
The synthesized cDNAs were used as templates for real-time PCR.
Real-time quantitative PCR was performed using pre-developed
TaqManH Assay Reagents (assay IDs: Mm00443258_m1, TNF-a;
Mm00446190_m1, IL-6; Mm00516023_m1, ICAM-1; Mm011-
68134_m1, INF-c; Mm00445235_m1, IP-10; Mm00441242_m1,
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1b; Mm01302428_m1, RANTES; Mm00442754_m1, CD4;
Mm00438116_m1, CD8b1; Mm00434455_m1, CD11b;
Mm00515420_m1, CD19; Nm_007393.1, mouse beta actin;
Applied Biosystems) and TaqManH Gene Expression Master
Mix (Applied Biosystems) on a Rotor Gene-3000 (Corbett
Research). Mouse beta actin was used as a housekeeping gene.
The amplification conditions were as follows: initially, 2 minutes at
50uC (to allow UNG to destroy any contaminating templates); 10
minutes at 95uC (to denature UNG and activate the enzymes); 40
cycles of denaturation at 95uC for 15 seconds; and annealing/
extension at 60uC for 1 minute.
To calculate the fold change in gene expression, the CT of the
housekeeping gene was subtracted from the CT of the target gene
to yield the DCT. Change in expression of the normalized target
gene was expressed as 2
-DDCT where DDCT=DCT sample-DCT
control, as described previously [52].
Statistics
The survival of mice was analyzed using Kaplan-Meier survival
analysis. All other data were analyzed by one-way ANOVA,
followed by the Student-Newman-Keuls test for all pairwise
comparisons. Prior to ANOVA, Levene’s Test for Equality of
Variances was performed. All statistical analyses were performed
using MedCalc software, version 11.2.1.0.
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